Sirio Reports Substantial Growth in Emerging APAC Markets

The nutraceutical business is booming in the APAC region, reports global nutraceutical CDMO Sirio Pharma, with growth driven by rising demand in key markets like Singapore, Australia, Thailand, and Indonesia. The company is set to begin construction on a new manufacturing facility in Thailand in order to meet rising demand.

According to the manufacturer, in the past 12 months, there has been a 77% growth in revenue in APAC markets, excluding China, with biggest demand seen in fish oil supplements, multivitamins, and high-dose sports nutrition gummies in Australia; and collagen-based beauty supplements, biotin, and sour-flavored sports nutrition gummies in Singapore.

Thailand, Indonesia, and India typically follow these markets, and Sirio expects these markets to emerge in the next few years.

In Australia, muscle gain and recovery formulas are major growth drivers, and it has introduced gummies featuring protein, creatine, and BCAAs to offer functional benefits with no need for pills or mixing.

In Thailand, active lifestyles are driving uptake of micro-effervescent vitamins and sports gummies. Indonesia, meanwhile, is seeing a surge of interest for halal-certified supplements, alongside demand for Zone IVb-stable formulations that can streamline regulatory approvals. In India, vegetarian softgels and beauty supplements are especially popular, particularly those which feature collagen or biotin.

Across the entire APAC region, women’s health is a highlight, and collagen, biotin, iron, and bioavailable peptides are popular for supporting holistic well-being, Sirio noted. Technologies like its collagen-based gummy, developed without traditional gelling agents, have strong potential for clean labels and higher active loads.

“These shifts across Southeast Asia are accelerating demand for innovative formats,” said Alex Du, general manager of Asia Pacific BU at Sirio Pharma. “We’re focused on helping our partners bring differentiated products to market quickly. Our innovation-led model enables them to lead in emerging categories, often securing first-mover advantage. Together with our partners, we’re growing rapidly across these high-potential nutraceutical markets.”